Literature DB >> 28743604

Clinicopathological features, management and outcome of patients with poorly-differentiated oral and oropharyngeal squamous cell carcinoma.

Zhien Feng1, Qiao Shi Xu1, Chong Wang1, Bo Li1, Jin Zhong Li1, Ming Hui Mao1, Hua Li1, Li Zheng Qin1, Zhengxue Han2.   

Abstract

BACKGROUND: The purpose of this study was to explore the clinicopathological features, risk factors, and management of poorly differentiated oral and oropharyngeal squamous cell carcinoma (OOSCC) patients in the northern Chinese population.
METHOD: A total of 118 poorly differentiated OOSCC patients from 2236 consecutive cases were retrospectively enrolled in this study.
RESULTS: Cox regression analysis showed that site (hazard ratio (HR): 2.561, 95% confidence interval (CI): 1.064-6.164, p = 0.036) and lymph node ratio (LNR) (HR: 3.915, 95% CI: 1.797-8.530, p = 0.001) were independent predictive factors for 5-year disease-specific survival (DSS). LNR >0.036, oropharynx site, and advanced clinical stage formulate a model of risk stratification. The patients with a risk score of ≥2 were identified as the high-risk population, and patients with a risk score of 0 or 1 were identified as the low-risk population. Patients in the high-risk population who underwent surgery plus concurrent chemoradiotherapy (CCRT) had markedly better 5-year DSS than those who only underwent surgery (60.0% vs. 20.0%, p = 0.016). However, patients in the low-risk population who underwent surgery alone exhibited a similar 5-year DSS (68.2%) compared with those who received surgery plus radiotherapy (RT) (68.2%) or surgery plus CCRT (50.0%) (p = 0.907).
CONCLUSIONS: High LNR, oropharynx site and advanced clinical stage constitute a model of risk stratification for patients with poorly differentiated OOSCC. If two or more risk factors are present, surgery and adjuvant chemoradiotherapy can give the best prognosis.
Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Oral cavity; Oropharynx; Poor differentiation; Prognosis; Risk factors; Squamous cell carcinoma

Mesh:

Year:  2017        PMID: 28743604     DOI: 10.1016/j.jcms.2017.06.013

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  3 in total

1.  Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China.

Authors:  Shuo Ding; Wei Guo; Gaofei Yin; Nuan Li; Hongfei Liu; Junwei Huang; Zheng Yang; Hongbo Xu; Xiaohong Chen; Yang Zhang; Zhigang Huang
Journal:  Ann Transl Med       Date:  2022-06

2.  RASSF-1A modulates proliferation-mediated oral squamous cell carcinoma progression.

Authors:  Jianli Sun
Journal:  Cancer Cell Int       Date:  2019-08-13       Impact factor: 5.722

3.  PLAC8 inhibits oral squamous cell carcinogenesis and epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt/GSK3β signaling pathways.

Authors:  Junlu Wu; Xuetao Wang; Anquan Shang; Giovanna Vella; Zujun Sun; Ping Ji; Dianyu Yang; Aiming Wan; Yiwen Yao; Dong Li
Journal:  Oncol Lett       Date:  2020-08-19       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.